Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Sandaltzopoulos

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Current Vascular Pharmacology|October 5, 2016
Editorial: The microRNA 221/222 Cluster: Inaugurating a New Era in Cardiovascular Disease and Cancer?Konstantinos Imprialos, M Doumas, Maria Tokamani, et al.
Cancer Letters|April 2, 2008
Reactive oxygen species and HIF-1 signalling in cancerAlex Galanis, Aglaia Pappa, Antonis Giannakakis, et al.
The International Journal of Biochemistry & Cell Biology|August 3, 2011
Biochemical and molecular analysis of the interaction between ERK2 MAP kinase and hypoxia inducible factor-1αAthanasios Karapetsas, Antonis Giannakakis, Maria Pavlaki, et al.
International Journal of Nanomedicine|May 3, 2014
Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancerEfthymia-Iliana Matthaiou, Jaleh Barar, Raphael Sandaltzopoulos, et al.
Cancer Biomarkers : Section a of Disease Markers|November 3, 2011
Tumor vascular biomarkers: new opportunities for cancer diagnosticsChunsheng Li, Dimitra Sasaroli, Xiang Chen, et al.
The International Journal of Biochemistry & Cell Biology|June 1, 2014
Overexpression of SMARCE1 is associated with CD8+ T-cell infiltration in early stage ovarian cancerAntonis Giannakakis, Athanasios Karapetsas, Denarda Dangaj, et al.
Biomedicines|March 31, 2018
Roles of NF-κB Signaling in the Regulation of miRNAs Impacting on Inflammation in CancerGeorgios S Markopoulos, Eugenia Roupakia, Maria Tokamani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 1, 2011
Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptorEvripidis Lanitis, Mathilde Poussin, Ian S Hagemann, et al.
Molecular Cancer Research : MCR|April 1, 2010
TAF4b and Jun/activating protein-1 collaborate to regulate the expression of integrin alpha6 and cancer cell migration propertiesMargarita Kalogeropoulou, Angeliki Voulgari, Vassiliki Kostourou, et al.
Cancer Immunology Research|January 11, 2014
Chimeric antigen receptor T Cells with dissociated signaling domains exhibit focused antitumor activity with reduced potential for toxicity in vivoEvripidis Lanitis, Mathilde Poussin, Alex W Klattenhoff, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Current Vascular Pharmacology|October 5, 2016
Editorial: The microRNA 221/222 Cluster: Inaugurating a New Era in Cardiovascular Disease and Cancer?Konstantinos Imprialos, M Doumas, Maria Tokamani, et al.
Cancer Letters|April 2, 2008
Reactive oxygen species and HIF-1 signalling in cancerAlex Galanis, Aglaia Pappa, Antonis Giannakakis, et al.
The International Journal of Biochemistry & Cell Biology|August 3, 2011
Biochemical and molecular analysis of the interaction between ERK2 MAP kinase and hypoxia inducible factor-1αAthanasios Karapetsas, Antonis Giannakakis, Maria Pavlaki, et al.
International Journal of Nanomedicine|May 3, 2014
Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancerEfthymia-Iliana Matthaiou, Jaleh Barar, Raphael Sandaltzopoulos, et al.
Cancer Biomarkers : Section a of Disease Markers|November 3, 2011
Tumor vascular biomarkers: new opportunities for cancer diagnosticsChunsheng Li, Dimitra Sasaroli, Xiang Chen, et al.
The International Journal of Biochemistry & Cell Biology|June 1, 2014
Overexpression of SMARCE1 is associated with CD8+ T-cell infiltration in early stage ovarian cancerAntonis Giannakakis, Athanasios Karapetsas, Denarda Dangaj, et al.
Biomedicines|March 31, 2018
Roles of NF-κB Signaling in the Regulation of miRNAs Impacting on Inflammation in CancerGeorgios S Markopoulos, Eugenia Roupakia, Maria Tokamani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 1, 2011
Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptorEvripidis Lanitis, Mathilde Poussin, Ian S Hagemann, et al.
Molecular Cancer Research : MCR|April 1, 2010
TAF4b and Jun/activating protein-1 collaborate to regulate the expression of integrin alpha6 and cancer cell migration propertiesMargarita Kalogeropoulou, Angeliki Voulgari, Vassiliki Kostourou, et al.
Cancer Immunology Research|January 11, 2014
Chimeric antigen receptor T Cells with dissociated signaling domains exhibit focused antitumor activity with reduced potential for toxicity in vivoEvripidis Lanitis, Mathilde Poussin, Alex W Klattenhoff, et al.
Pageof 5